Our research plan involved the pretreatment of male rats by icv delivery of the α1-AR reverse-agonist prazocin (PRZ) or vehicle ahead of induction of a single versus final episode (e.g., occurring on the fourth consecutive day of insulin administration) of hypoglycemia. The gene discussed is INS; the disease is Hypoglycemia.